Silence Therapeutics plc SLN

$ 17.94 0.62%

Annual report 2023
added 10-19-2024

Silence Therapeutics plc EV/EBITDA Ratio 2011-2024 | SLN

Annual EV/EBITDA Ratio Silence Therapeutics plc

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-34.9	-21.4	-	-	-	-	-0.106	-	-	-	-

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.106	-34.9	-18.8